Product image of Ionolyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate) supplied by GNH India

Ionolyte

Active Ingredient:
Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate
Origin:
EU

Ionolyte (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate)

Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride and Sodium Acetate Trihydrate, the active ingredients in Ionolyte, are an electrolyte solution presented as an injectable solution for intravenous use. It is used to correct electrolyte depletion and support fluid balance in patients undergoing surgery, critical care, or experiencing electrolyte loss.

GNH India supplies Ionolyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Fresenius Kabi Deutschland Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ionolyte is an intravenous electrolyte solution used to manage disorders of fluid and electrolyte balance.
  • Electrolyte depletion: restores magnesium, potassium, sodium and acetate concentrations to physiologic levels.
  • Fluid replacement therapy: provides isotonic fluid volume to maintain intravascular volume.
  • Peri‑operative care: maintains electrolyte homeostasis during surgery or critical‑care interventions.

How It Works

  • Ionolyte delivers magnesium, potassium, sodium and acetate ions directly into the bloodstream. The ions participate in cellular osmotic regulation, nerve impulse transmission, muscle contraction and acid‑base balance. By supplementing these electrolytes, the solution helps re‑establish extracellular fluid composition and supports physiological processes that depend on optimal electrolyte concentrations.

Side Effects

Ionolyte may be associated with infusion‑related reactions and electrolyte‑related abnormalities.

Common Side Effects

  • Mild infusion site irritation or erythema.
  • Transient hypermagnesemia causing mild hypotension.
  • Slight increase in serum potassium leading to mild nausea.
  • Temporary rise in serum sodium with mild thirst.
  • Mild metabolic alkalosis from acetate metabolism.

Serious or Rare Side Effects

  • Severe hypermagnesemia with respiratory depression.
  • Life‑threatening hyperkalemia causing cardiac arrhythmia.
  • Hypernatremia leading to neurologic symptoms.
  • Acute acetate toxicity resulting in metabolic acidosis.
  • Anaphylactic reaction to solution components.

Precautions & Warnings

  • Ionolyte should be administered with careful clinical monitoring.
  • Assess baseline electrolytes: obtain serum magnesium, potassium, sodium and acid‑base status before infusion.
  • Renal impairment: adjust infusion rate and monitor electrolytes closely.
  • Cardiac disease: watch for arrhythmias when correcting potassium or magnesium.
  • Fluid overload risk: limit total volume in patients with heart failure.
  • Pregnancy and lactation: use only if clearly indicated after risk‑benefit assessment.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Ionolyte may interact with drugs that affect electrolyte balance or cardiac conduction.

Major Interactions (Avoid)

  • Concurrent high‑dose potassium supplements: risk of severe hyperkalemia.
  • Magnesium‑containing laxatives or antacids: may cause excessive magnesium levels.
  • Sodium‑rich IV fluids: can precipitate hypernatremia.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: may potentiate potassium elevation.
  • Digoxin: altered potassium may affect drug toxicity.
  • Loop diuretics: increased electrolyte loss may require dose adjustment of Ionolyte.

Frequently Asked Questions

Ionolyte is an intravenous electrolyte solution used to replace lost magnesium, potassium, sodium and acetate ions. It is indicated for patients with electrolyte depletion, for fluid replacement during surgery or critical‑care situations, and to maintain electrolyte balance in various clinical settings.

The active ingredients—magnesium chloride hexahydrate, potassium chloride, sodium chloride and sodium acetate trihydrate—dissolve into their respective ions after infusion. These ions participate in osmotic regulation, nerve and muscle function, and acid‑base balance, helping to restore normal extracellular fluid composition.

The dose of Ionolyte is determined by the prescribing clinician based on the patient’s electrolyte status, fluid needs and clinical condition. The healthcare professional calculates the appropriate volume and infusion rate for each individual case.

Safety data for Ionolyte in pregnancy and lactation are limited. It should be used only when clearly needed and after a careful risk‑benefit assessment by the treating physician.

To order Ionolyte, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and necessary import documentation.

Ionolyte provides a balanced combination of magnesium, potassium, sodium and acetate, whereas many standard saline solutions contain only sodium and chloride. This broader electrolyte profile can reduce the need for additional supplementation in patients who require multiple ion replacements.

Ionolyte should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use to maintain sterility and stability.

Ionolyte is administered intravenously as a sterile solution. The infusion is given through a suitable IV line, with the rate adjusted according to the patient’s electrolyte levels and clinical condition, under the supervision of qualified healthcare personnel.

Serious risks include severe hypermagnesemia, hyperkalemia or hypernatremia, which can lead to cardiac arrhythmias, respiratory depression or neurologic complications. Prompt monitoring of serum electrolytes during and after infusion is essential to detect and manage these events.

Ionolyte should be avoided in patients with known hypersensitivity to any of its components, in those with uncontrolled hypermagnesemia, hyperkalemia or hypernatremia, and in individuals with severe renal impairment unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Sodium Acetate Trihydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT